Skip to the page

Data / Drug companies / Dextromethorphan hydrobromide, guaifenesin

Dextromethorphan hydrobromide, guaifenesin: 49 companies and 86 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Dextromethorphan hydrobromide, guaifenesin is listed in the FDA National Drug Code Directory by 49 companies, with 86 products in commercial distribution. 20 of the products (23.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; tablet, extended release; liquid, and the newest product started marketing on July 15, 2026.

The request: Get every company that lists dextromethorphan hydrobromide, guaifenesin in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
49
Products
86
Generic (ANDA) products
20 (23.3%)
Application numbers
6
Routes
Oral, Topical
Brand names
Adult Tussin DM, Good Sense Tussin DM, Mucus Relief DM, Good Sense Mucus DM, Giltuss HBP Cough and Chest Congestion, Giltuss Childrens Cough and Chest Congestion, Mucus Relief DM, Rugby Mucus Relief DM Er
openFDA record search
api.fda.gov

Companies that list dextromethorphan hydrobromide, guaifenesin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
CVS Woonsocket Prescription Center, Incorporated6solution; tablet, extended releaseOver the counter monograph drugsMarch 3, 2026
Rugby Laboratories4tablet, extended release; liquidOver the counter monograph drugsApril 16, 2025
Walgreen Company4tablet, extended release; solutionGeneric drugs (ANDA)February 5, 2024
A-S Medication Solutions3solution; tablet, extended releaseOver the counter monograph drugsApril 16, 2025
Amerisource Bergen3solution; tablet, extended releaseOver the counter monograph drugsSeptember 12, 2025
Dextrum Laboratories, Inc3solutionOver the counter monograph drugsNovember 13, 2018
Dolgencorp, Inc. (dollar General & Rexall)3solution; tablet, extended releaseOver the counter monograph drugsJuly 1, 2026
Gil Pharmaceutical Corp3solutionOver the counter monograph drugsNovember 13, 2018
Haleon US Holdings LLC3tablet, extended release; liquidOver the counter monograph drugsJune 14, 2019
Preferred Pharmaceuticals Inc.3solutionOver the counter monograph drugsJanuary 23, 2023
Reckitt Benckiser LLC3liquid; tablet, coatedOver the counter monograph drugsJuly 1, 2025
Rite Aid Corporation3solution; tablet, extended releaseOver the counter monograph drugsMarch 15, 2023
Cardinal Health 110, LLC. DBA Leader2tablet, extended release; solutionGeneric drugs (ANDA)March 8, 2025
Discount Drug Mart2liquidOver the counter monograph drugsNovember 19, 2014
Gadal Laboratories, Inc2liquid; syrupOver the counter monograph drugsApril 14, 2025
L. Perrigo Company2tablet, extended release; solutionGeneric drugs (ANDA)April 16, 2022
Meijer, Inc.2solutionOver the counter monograph drugsJuly 1, 2026
United Natural Foods, Inc. DBA Unfi2tablet, extended release; solutionGeneric drugs (ANDA)June 8, 2022
Vivunt Pharma LLC2liquidOver the counter monograph drugsMay 14, 2024
Walmart Inc.2solution; tablet, extended releaseOver the counter monograph drugsJune 17, 2022
Actipharma, LLC1liquidOver the counter monograph drugsFebruary 12, 2026
Advanced Generic Corporation1liquidOver the counter monograph drugsJuly 1, 2012
Amazon.com Services LLC1solutionOver the counter monograph drugsJuly 22, 2022
AptaPharma Inc.1liquidOver the counter monograph drugsJanuary 30, 2024
Bayer HealthCare LLC.1tablet, effervescentOver the counter monograph drugsApril 5, 2022
CVS Pharmacy1solutionOver the counter monograph drugsJuly 12, 2022
Demoulas Super Markets, Inc1liquidOver the counter monograph drugsOctober 1, 2012
H E B1liquidOver the counter monograph drugsSeptember 14, 2012
H E B1solutionOver the counter monograph drugsApril 22, 2022
HyVee Inc1tablet, extended releaseGeneric drugs (ANDA)February 25, 2026
Kramer Novis1syrupOver the counter monograph drugsOctober 2, 2013
Magno-Humphries, Inc.1tabletOver the counter monograph drugsApril 4, 2017
Major Pharmaceuticals1solutionOver the counter monograph drugsJanuary 7, 2022
Meijer Distribution Inc1tablet, extended releaseGeneric drugs (ANDA)June 2, 2020
Menper Distributors, Inc.1liquidOver the counter monograph drugsApril 1, 2019
Navajo Manufacturing Company Inc.1tablet, extended releaseNew drug applications (NDA)September 23, 2016
Publix Super Markets Inc1solutionOver the counter monograph drugsJuly 21, 2022
Retail Business Services, LLC1solutionOver the counter monograph drugsJuly 13, 2022
Safeway1solutionOver the counter monograph drugsJuly 15, 2026
Salado Sales, Inc.1liquidOver the counter monograph drugsJanuary 1, 2012
Sato Pharmaceutical Co., Ltd.1syrupOver the counter monograph drugsJanuary 3, 2001
Southern Sales & Service, Inc.1liquidOver the counter monograph drugsFebruary 1, 2023
Sportpharm LLC1tablet, extended releaseGeneric drugs (ANDA)July 10, 2019
Strategic Sourcing Services LLC1solutionOver the counter monograph drugsOctober 25, 2023
Strive Pharmaceuticals Inc.1tabletOver the counter monograph drugsJune 1, 2026
Target Corporation1tablet, extended releaseGeneric drugs (ANDA)July 15, 2019
Topco Associates LLC1tablet, extended releaseGeneric drugs (ANDA)July 10, 2019
Topco Associates LLC1solutionOver the counter monograph drugsMay 11, 2022
Valu Merchandisers Company1liquidOver the counter monograph drugsSeptember 30, 2018

Dosage forms

Dosage formProductsShare
Solution3945.3%
Tablet, extended release2124.4%
Liquid1719.8%
Syrup33.5%
Tablet22.3%
Capsule, liquid filled22.3%
Tablet, coated11.2%
Tablet, effervescent11.2%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs6575.6%
Generic drugs (ANDA)2023.3%
New drug applications (NDA)11.2%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.